BCRX vs PTHS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

BCRX

38.8
AI Score
VS
PTHS Wins

PTHS

47.1
AI Score

Investment Advisor Scores

BCRX

39score
Recommendation
AVOID NEW MONEY

PTHS

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BCRX PTHS Winner
Forward P/E 13.0378 0 Tie
PEG Ratio 9.3878 0 Tie
Revenue Growth 13.1% 0.0% BCRX
Earnings Growth 133.3% 0.0% BCRX
Tradestie Score 38.8/100 47.1/100 PTHS
Profit Margin -37.4% -199.5% BCRX
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD PTHS

Relative Price Performance (Last 90 Days)

BCRX 1M: -4.6% · 3M: -21.1% PTHS 1M: -60.3% · 3M: -70.8%

Current Technical Phase

BCRX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.3%), weak momentum, RSI 42

RSI (14): 42.2 · Price: $7.68

PTHS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -22.0%), weak momentum, RSI 26

RSI (14): 26.1 · Price: $8.03

Fundamentals Snapshot

Metric BCRX PTHS
Market Cap — —
Forward P/E 9.0 -1.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.8% 0.8%
Operating Margin 0.5% -1.3%
EPS -1.28 -27.53
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PTHS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.